Latest filing published 01 Sept 2015 for Kiora Pharmaceuticals INC.
Insider track record
No signal scores available.
Thomas Balland: trading record in brief
Thomas Balland discloses dealings in Kiora Pharmaceuticals Inc to SEC (Form 4). Over a trading history stretching from 1 May 2015 to 28 August 2015, the count stands at 2 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
On 1 September 2015 came the latest disclosure, a share grant in Kiora Pharmaceuticals Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Thomas Balland
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 5,037 shares0Common StockSEC:0001144204-15-053236:0
- 10,422 shares0Common StockSEC:0001144204-15-027687:0
2 of 2 declarations